StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30243% above fair value
$14.17−0.31 (-2.14%)

Close on Nov 17, 2026Market cap $5.41BP/E 109.0Yield –

LifeStance Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

LifeStance Health's operating income for the twelve months ending Jun 30, 2026 was $78.43M. For fiscal 2025 it was $24.15M. The highest annual figure on record is $24.15M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.15M–
FY2024Dec 31, 2024-$31.61M–
FY2023Dec 31, 2023-$189.13M–
FY2022Dec 31, 2022-$210.17M–
FY2021Dec 31, 2021-$286.35M-1978.8%
FY2019Dec 31, 2019$15.24M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$30.65M–
Q1 FY2026Mar 31, 2026$22.28M+1289.3%
Q4 FY2025Dec 31, 2025$18.08M+1607.6%
Q3 FY2025Sep 30, 2025$7.41M+15666.0%
Q2 FY2025Jun 30, 2025-$2.95M–
Q1 FY2025Mar 31, 2025$1.60M–
Q4 FY2024Dec 31, 2024$1.06M–
Q3 FY2024Sep 30, 2024$47.00K–
Q2 FY2024Jun 30, 2024-$15.95M–
Q1 FY2024Mar 31, 2024-$16.77M–
Q4 FY2023Dec 31, 2023-$32.27M–
Q3 FY2023Sep 30, 2023-$74.36M–
Q2 FY2023Jun 30, 2023-$48.41M–
Q1 FY2023Mar 31, 2023-$34.09M–
Q4 FY2022Dec 31, 2022-$46.01M–
Q3 FY2022Sep 30, 2022-$38.84M–
Q2 FY2022Jun 30, 2022-$60.47M–
Q1 FY2022Mar 31, 2022-$64.85M–
Q4 FY2021Dec 31, 2021-$113.76M-4327.4%
Q3 FY2021Sep 30, 2021-$124.67M-119973.1%
Q2 FY2021Jun 30, 2021-$47.05M–
Q1 FY2021Mar 31, 2021-$881.00K–
Q3 FY2020Sep 30, 2020$2.69M–
Q2 FY2020Jun 30, 2020$104.00K–

More LifeStance Health figures

See a number that looks wrong?